Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00465855 · ClinicalTrials.gov registry record · Phase 4
One vs. Three Hyperbaric Oxygen Treatments for Acute Carbon Monoxide Poisoning
A Phase 4 study, sponsored by Intermountain Health Care.
- Completed
- Registry status
- Phase 4
- Development phase
- 75
- Enrollment target
NCT00465855 is a Phase 4 study that has completed, run by Intermountain Health Care. The registered enrollment target is 75 participants.
The verdict
NCT00465855, a Phase 4 study, has completed, sponsored by Intermountain Health Care.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 75 participants
- Enrollment target
Study Summary
This randomized trial will investigate important clinical outcomes of patients with acute carbon monoxide poisoning randomized to receive either one or three hyperbaric oxygen treatments.
Interventions
- COMBINATION_PRODUCT Hyperbaric Oxygen (HBO2) - 3 sessions
- COMBINATION_PRODUCT Hyperbaric Oxygen (HBO2) - 1 session
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 75 participants |
| Start Date | 2007-06-03 |
| Est. Completion | 2017-01-28 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00465855
The ClinicalTrials.gov registry entry for NCT00465855 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 75 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Intermountain Health Care, which has 85 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Hyperbaric Oxygen (HBO2) - 3 sessions is the first listed.
NCT00465855 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00465855 about?
NCT00465855 is a clinical study titled "One vs. Three Hyperbaric Oxygen Treatments for Acute Carbon Monoxide Poisoning". This randomized trial will investigate important clinical outcomes of patients with acute carbon monoxide poisoning randomized to receive either one or three hyperbaric oxygen treatments.
What is the current status of trial NCT00465855?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 75 participants. The study started on 2007-06-03. Estimated completion is 2017-01-28.
What interventions are being tested in trial NCT00465855?
The interventions under investigation include: Hyperbaric Oxygen (HBO2) - 3 sessions (COMBINATION_PRODUCT), Hyperbaric Oxygen (HBO2) - 1 session (COMBINATION_PRODUCT).
Who is sponsoring clinical trial NCT00465855?
This trial is sponsored by Intermountain Health Care, which has 85 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.